Swift Biosciences Sweeps Up $3M

Xconomy Detroit/Ann Arbor — 

Swift Biosciences, an Ann Arbor, MI, company that makes reagents for genetic tests, has announced that it received $3 million in Series A financing in June led by VC firm DFJ Mercury and joined by several Michigan-based investors. Swift was founded in January by former Accuri Cytometers Chief Scientific Officer David Olson. “Swift Biosciences plans to grow operations and launch products next year,” Olson says in an e-mail to me this morning. “I think the Ann Arbor area is a great place for us.” As we reported in May, Houston-based DFJ Mercury is actively seeking investment opportunities in Michigan.

By posting a comment, you agree to our terms and conditions.

Comments are closed.